FDA Approves Drug to Treat Duchenne Muscular Dystrophy, but Congress Has Problems

The price of Emflaza, from Marathon Pharmaceuticals, is met with criticism from Congress. Read more.

POPULAR ON THE WEB

Meeting the Pharmacy Needs of Tourists, Vacationers, and Travelers

Community Pharmacies Prevent Prescription Fraud

First Do No Harm

EDITOR'S CHOICE

Faulty Drug Interaction Overrides: We Have to Do Better

Inside The Latest Issue

Finding Time to Counsel Patients: Make It the Priority

February 16, 2017

Continuing education

New Options When Statins Are Not Enough

Key cogs in the management of Parkinson's disease

Addressing unique medication adherence issues for patients with schizophrenia

Get the free app!

Part of the

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply.
Please use the links provided if you have questions or concerns regarding this email or your subscription.

This email was sent by: %%Member_Busname%%
%%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%

NEWSLETTER

Forward to a Friend
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters
Contact Us